Monday, 28 September 2026Updated 9m ago

← Top stories

FORTIS

Fortis Healthcare Limited · ₹837.85 −4.5% on 25 Sept · 1M −8.3% · 3M −11.8% · 4 stories in 60 days · 0 positive · 1 negative

Open the company tag: stories, tone, the tags it comes with →

Price and news

NSE daily close · markers = sessions where news first traded

Positive newsNegative newsNeutral

Legal●Developing · 4

Fortis distances itself from Daiichi-Singh dispute as Supreme Court permits forensic audit

Fortis said it had no involvement in the Daiichi Sankyo-Singh brothers dispute
The Supreme Court allowed the forensic audit to proceed
Fortis shareholders may watch for any fallout from the audit despite the company denying involvement

Fortis Healthcare Daiichi Sankyo Singh brothers Supreme Court3 sources · 1h

Legal●Developing · 4

Fortis says independent audit will establish non-involvement in Singh brothers’ share transfers

Supreme Court cleared the way for an independent forensic audit of the share transfers
The court said the Delhi High Court’s earlier observations were provisional
The audit outcome may affect Fortis Healthcare’s governance and investor confidence

Fortis Healthcare Supreme Court Pharma and healthcare Singh brothers2 sources · 14h

Legal●Developing · 4

Fortis confident of clean chit from audit in Singh brothers’ dispute

Fortis expects a clean chit from the audit in the Singh brothers’ dispute
The Supreme Court allowed the audit to proceed while clarifying the Delhi High Court’s observations against Fortis
The audit outcome may affect Fortis Healthcare’s governance and valuation

Fortis Healthcare Supreme Court Hospitals Pharma and healthcare Asset quality1 source · 16h

Legal▼Developing · 4

Supreme Court allows independent forensic audit of Fortis transactions in Daiichi dispute

The Supreme Court declined to interfere with Delhi High Court orders allowing the audit
The dispute is linked to a ₹3,500 crore arbitral award in Daiichi Sankyo’s favour
Audit scrutiny may affect Fortis Healthcare investors and the company’s governance outlook

Fortis Healthcare−4.5%Daiichi Sankyo Supreme Court Pharma and healthcare6 sources · 20h